NICOTINE TRANSDERMAL SYSTEM patch, extended release

Nicotine Transdermal System by

Drug Labeling and Warnings

Nicotine Transdermal System by is a Otc medication manufactured, distributed, or labeled by Apotex Corp., Aveva Drug Delivery Systems, Aveva Drug Delivery Systems Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Fact

Active ingredient (in each patch)  

Step 1 - Nicotine, 21 mg delivered over 24 hours

Step 2 - Nicotine, 14 mg delivered over 24 hours

Step 3 - Nicotine, 7 mg delivered over 24 hours

Purpose

Stop smoking aid

Use

reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking.

Warnings

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Ask a doctor before use if you have

• heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
• high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
• an allergy to adhesive tape or have skin problems, because you are more likely to get rashes.
• stomach ulcer or diabetes
• history of seizures

Ask a doctor or pharmacist before use if you are

• using a non-nicotine stop smoking drug
• taking a prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

When using this product

• if you have vivid dreams or other sleep disturbances remove this patch at bedtime

Stop use and ask a doctor if

• skin redness caused by the patch does not go away after four days, or if your skin swells, or you get a rash
• irregular heartbeat or palpitations occur
• you get symptoms of nicotine overdose, such as nausea, vomiting, dizziness, weakness and rapid heartbeat.
• you have symptoms of an allergic reaction (such as difficulty breathing or rash)

Keep out of reach of children and pets.

Used patches have enough nicotine to poison children and pets. If swallowed, get medical help or contact a Poison Control Center right away. Save pouch to use for patch disposal. Dispose of the used patches by folding sticky ends together and putting in pouch.

Directions

• if you are under 18 years of age, ask a doctor before use  
• before using this product, read the enclosed self-help guide for complete directions and other information
• begin using the patch on your quit day
• if yousmoke more than 10 cigarettes per day, use the following schedule below:

  Weeks 1 thru 2	Weeks 5 and 6	Weeks 7 and 8
  Step 1	Step 2	Step 3
  Use one 21 mg patch/day	Use one 14 mg patch/day	Use one 7 mg patch/day

• if you smoke 10 or less cigarettes per day, start with Step 2 for 6 weeks, then Step 3 for 2 weeks
• apply one new patch every 24 hours on skin that is dry, clean and hairless
• remove backing from patch and immediately press onto skin. Hold for 10 seconds.
• wash hands after applying or removing patch. Save pouch to use for patch disposal. Dispose of the used patches by folding sticky ends together and putting in pouch.
• the used patch should be removed and a new one applied to a different skin site at the same time each day
• if you have vivid dreams, you may remove the patch at bedtime and apply a new one in the morning
• do not wear more than one patch at a time
• do not cut patch in half or into smaller pieces
• do not leave patch on for more than 24 hours because it may irritate your skin and loses strength after 24 hours
• it is important to complete treatment. If you feel you need to use the patch for a longer period to keep from smoking, talk to your health care provider.

Other information  

store at 20° C – 25° C (68° F – 77° F)

Inactive ingredients

acrylate adhesive, polyester, silicone adhesive

Comments or Questions?

1-844-562-7963

TO INCREASE YOUR SUCCESS IN QUITTING: 

1. You must be motivated to quit.

2. Use one patch daily according to directions.

3. It is important to complete treatment.

4. If you feel you need to use the patch for a longer period to keep from smoking, talk to your health care provider.

5. Use patch with a behavioral support program such as the one described in the enclosed booklet.

PRINCIPAL DISPLAY PANEL - 14 mg CARTON

Nicotine Transdermal System

NDC No. 60505-7089-0

14 Patches

PRINCIPAL DISPLAY PANEL - 7 mg CARTON

Nicotine Transdermal System

NDC No. 60505-7088-0

14 Patches

PRINCIPAL DISPLAY PANEL- 21 mg CARTON

Nicotine Transdermal System

NDC No. 60505-7090-0

14 Patches

INGREDIENTS AND APPEARANCE

NICOTINE TRANSDERMAL SYSTEM 
nicotine transdermal system patch, extended release

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 60505-7089
Route of Administration	TRANSDERMAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Nicotine (UNII: 6M3C89ZY6R) (Nicotine - UNII:6M3C89ZY6R)	Nicotine	14 mg  in 24 h

Inactive Ingredients
Ingredient Name	Strength
Dimethicone (UNII: 92RU3N3Y1O)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 60505-7089-0	14 in 1 CARTON	01/11/2019
1		1 h in 1 POUCH; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANDA	ANDA074612	01/11/2019

NICOTINE TRANSDERMAL SYSTEM 
nicotine transdermal system patch, extended release

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 60505-7088
Route of Administration	TRANSDERMAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Nicotine (UNII: 6M3C89ZY6R) (Nicotine - UNII:6M3C89ZY6R)	Nicotine	7 mg  in 24 h

Inactive Ingredients
Ingredient Name	Strength
Dimethicone (UNII: 92RU3N3Y1O)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 60505-7088-0	14 in 1 CARTON	01/11/2019
1		1 h in 1 POUCH; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANDA	ANDA074612	01/11/2019

NICOTINE TRANSDERMAL SYSTEM 
nicotine transdermal system patch, extended release

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 60505-7090
Route of Administration	TRANSDERMAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Nicotine (UNII: 6M3C89ZY6R) (Nicotine - UNII:6M3C89ZY6R)	Nicotine	21 mg  in 24 h

Inactive Ingredients
Ingredient Name	Strength
Dimethicone (UNII: 92RU3N3Y1O)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 60505-7090-0	14 in 1 CARTON	01/11/2019
1		1 h in 1 POUCH; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANDA	ANDA074612	01/11/2019

Labeler - Apotex Corp. (845263701)

Registrant - Aveva Drug Delivery Systems (783982093)

Establishment
Name	Address	ID/FEI	Business Operations
Aveva Drug Delivery Systems		783982093	analysis(60505-7089, 60505-7088, 60505-7090) , manufacture(60505-7089, 60505-7088, 60505-7090)